Childhood cancers trials in Belgium

In Belgium 85 Also abroad 2483

85 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Antwerp, Ghent, Leuven, Roeselare
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
Phase 2Taking people
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Where
Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
Age
Up to 17 years
People
250 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00
Phase 2/3Not yet taking people in Belgium
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Where
Leuven
Age
Up to 25 years
People
210 worldwide
Run by
University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00
No phaseTaking people
Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
Where
Brussels
Age
Up to 80 years
People
425
Run by
Université Catholique de Louvain
See details and how to joinNCT07384897
No phaseTaking people
LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.
Where
Brussels
People
110
Run by
Jules Bordet Institute
See details and how to joinNCT07370597
Phase 1/2Taking people
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Where
Brussels, Edegem, Gent, Leuven, Sint-Lambrechts-Woluwe
Age
1 year to 64 years
People
160 worldwide
Run by
University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00
No phaseTaking people
International Leukemia Target Board
Where
Ghent
Age
0 years to 25 years
People
600 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05270096
Phase 1/2Taking people
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Where
Gent
Age
1 year to 25 years
People
65 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT04925609 · EU 2024-513412-10-00
Phase 1/2Taking people
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Where
Gent
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00
Phase 1/2Taking people
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Gent
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01
Phase 1/2Not yet taking people in Belgium
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Gent
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00
Phase 2Taking people
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
Where
Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
Age
1 month to 18 years
People
60 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01
No phaseNot yet taking people in Belgium
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
Where
Aalst, Brussels, Ghent, Kortrijk, Wilrijk
People
302 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06462963
No phaseTaking people
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
Where
Genk
People
350
Run by
Hasselt University
See details and how to joinNCT07087080
Phase 3Taking people
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Where
Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
Age
Up to 21 years
People
800 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00
No phaseEnrolling by invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
Where
Brussels
Age
1 day and over
People
500 worldwide
Run by
Prof. Valérie Mc Lin
See details and how to joinNCT06041906
No phaseNot yet taking people in Belgium
SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
Where
Zürich
Age
10 years to 19 years
People
4,000 worldwide
Run by
Biobizkaia Health Research Institute
See details and how to joinNCT06931847
No phaseNot yet taking people in Belgium
The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program
Where
Ghent
Age
14 years to 18 years
People
3,500 worldwide
Run by
Biobizkaia Health Research Institute
See details and how to joinNCT06922201
No phaseTaking people
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
Where
Leuven
People
246
Run by
Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT05344235
No phaseTaking people
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
Where
Aalst, Brussels, Ghent, Kortrijk, Leuven, Liège, Namur, Turnhout, Wilrijk
Age
12 years and over
People
2,000 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT03818503
Phase 4Taking people
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
Where
Gent, Liège
Age
12 years to 25 years
People
148 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT04646187 · EU 2024-516277-68-00
Phase 3Not yet taking people in Belgium
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
Where
Brussels, Ghent, Leuven, Liège
Age
Up to 18 years
People
170 worldwide
Run by
Vastra Gotaland Region
See details and how to joinNCT05477589
Phase 2/3Taking people
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
Where
Sint-Lambrechts-Woluwe
People
436 worldwide
Run by
The University Of Birmingham
See details and how to join2024-516078-31-00
Phase 3Taking people
NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years
Where
Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
Age
Up to 64 years
People
730 worldwide
Run by
Vaestra Goetalandsregionen
See details and how to joinNCT01828489 · EU 2024-518254-16-00
No phaseTaking people
Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10
Where
Brussels
Age
12 years to 36 years
People
142
Run by
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
See details and how to joinNCT06517927